Preclinical evaluation of the ROR1-targeting antibody-drug conjugates zilovertamab vedotin and VLS-211 against B-cell ALL patient-derived xenografts.
Saved in:
| Title: | Preclinical evaluation of the ROR1-targeting antibody-drug conjugates zilovertamab vedotin and VLS-211 against B-cell ALL patient-derived xenografts. |
|---|---|
| Authors: | Smith CM; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health UNSW Centre for Childhood Cancer Research, UNSW Sydney Sydney New South Wales Australia., Watts B; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health UNSW Centre for Childhood Cancer Research, UNSW Sydney Sydney New South Wales Australia., Evans K; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health UNSW Centre for Childhood Cancer Research, UNSW Sydney Sydney New South Wales Australia., Kosasih H; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health UNSW Centre for Childhood Cancer Research, UNSW Sydney Sydney New South Wales Australia., Mayoh C; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health UNSW Centre for Childhood Cancer Research, UNSW Sydney Sydney New South Wales Australia., Erickson SW; RTI International, Research Triangle Park North Carolina USA., Earley EJ; RTI International, Research Triangle Park North Carolina USA., Neuhauser S; The Jackson Laboratory for Mammalian Genetics Bar Harbor Maine USA., Stearns TM; The Jackson Laboratory for Mammalian Genetics Bar Harbor Maine USA., Philip VM; The Jackson Laboratory for Mammalian Genetics Bar Harbor Maine USA., Chuang JH; The Jackson Laboratory for Genomic Medicine Farmington Connecticut USA., de Bock CE; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health UNSW Centre for Childhood Cancer Research, UNSW Sydney Sydney New South Wales Australia., Bowman EP; Department of Oncology Merck & Co. Inc. Rahway New Jersey USA., Jessen KA; Formerly VelosBio Inc. San Diego California USA., Jocoy EL; The Jackson Laboratory Sacramento California USA., Bult CJ; The Jackson Laboratory for Mammalian Genetics Bar Harbor Maine USA., Teicher BA; National Cancer Institute Bethesda Maryland USA., Smith MA; National Cancer Institute Bethesda Maryland USA., Lock RB; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health UNSW Centre for Childhood Cancer Research, UNSW Sydney Sydney New South Wales Australia. |
| Source: | HemaSphere [Hemasphere] 2026 Jul 22; Vol. 10 (7), pp. e70438. Date of Electronic Publication: 2026 Jul 22 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42488471 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Preclinical evaluation of the ROR1-targeting antibody-drug conjugates zilovertamab vedotin and VLS-211 against B-cell ALL patient-derived xenografts. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Smith+CM%22">Smith CM</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health UNSW Centre for Childhood Cancer Research, UNSW Sydney Sydney New South Wales Australia.<br /><searchLink fieldCode="AU" term="%22Watts+B%22">Watts B</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health UNSW Centre for Childhood Cancer Research, UNSW Sydney Sydney New South Wales Australia.<br /><searchLink fieldCode="AU" term="%22Evans+K%22">Evans K</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health UNSW Centre for Childhood Cancer Research, UNSW Sydney Sydney New South Wales Australia.<br /><searchLink fieldCode="AU" term="%22Kosasih+H%22">Kosasih H</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health UNSW Centre for Childhood Cancer Research, UNSW Sydney Sydney New South Wales Australia.<br /><searchLink fieldCode="AU" term="%22Mayoh+C%22">Mayoh C</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health UNSW Centre for Childhood Cancer Research, UNSW Sydney Sydney New South Wales Australia.<br /><searchLink fieldCode="AU" term="%22Erickson+SW%22">Erickson SW</searchLink>; RTI International, Research Triangle Park North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Earley+EJ%22">Earley EJ</searchLink>; RTI International, Research Triangle Park North Carolina USA.<br /><searchLink fieldCode="AU" term="%22Neuhauser+S%22">Neuhauser S</searchLink>; The Jackson Laboratory for Mammalian Genetics Bar Harbor Maine USA.<br /><searchLink fieldCode="AU" term="%22Stearns+TM%22">Stearns TM</searchLink>; The Jackson Laboratory for Mammalian Genetics Bar Harbor Maine USA.<br /><searchLink fieldCode="AU" term="%22Philip+VM%22">Philip VM</searchLink>; The Jackson Laboratory for Mammalian Genetics Bar Harbor Maine USA.<br /><searchLink fieldCode="AU" term="%22Chuang+JH%22">Chuang JH</searchLink>; The Jackson Laboratory for Genomic Medicine Farmington Connecticut USA.<br /><searchLink fieldCode="AU" term="%22de+Bock+CE%22">de Bock CE</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health UNSW Centre for Childhood Cancer Research, UNSW Sydney Sydney New South Wales Australia.<br /><searchLink fieldCode="AU" term="%22Bowman+EP%22">Bowman EP</searchLink>; Department of Oncology Merck & Co. Inc. Rahway New Jersey USA.<br /><searchLink fieldCode="AU" term="%22Jessen+KA%22">Jessen KA</searchLink>; Formerly VelosBio Inc. San Diego California USA.<br /><searchLink fieldCode="AU" term="%22Jocoy+EL%22">Jocoy EL</searchLink>; The Jackson Laboratory Sacramento California USA.<br /><searchLink fieldCode="AU" term="%22Bult+CJ%22">Bult CJ</searchLink>; The Jackson Laboratory for Mammalian Genetics Bar Harbor Maine USA.<br /><searchLink fieldCode="AU" term="%22Teicher+BA%22">Teicher BA</searchLink>; National Cancer Institute Bethesda Maryland USA.<br /><searchLink fieldCode="AU" term="%22Smith+MA%22">Smith MA</searchLink>; National Cancer Institute Bethesda Maryland USA.<br /><searchLink fieldCode="AU" term="%22Lock+RB%22">Lock RB</searchLink>; Children's Cancer Institute, Lowy Cancer Research Centre, School of Clinical Medicine, UNSW Medicine & Health UNSW Centre for Childhood Cancer Research, UNSW Sydney Sydney New South Wales Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101740619%22">HemaSphere</searchLink> [Hemasphere] 2026 Jul 22; Vol. 10 (7), pp. e70438. <i>Date of Electronic Publication: </i>2026 Jul 22 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101740619 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2572-9241 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225729241%22">25729241 </searchLink><i>NLM ISO Abbreviation: </i>Hemasphere <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42488471 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/hem3.70438 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e70438 Titles: – TitleFull: Preclinical evaluation of the ROR1-targeting antibody-drug conjugates zilovertamab vedotin and VLS-211 against B-cell ALL patient-derived xenografts. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Smith CM – PersonEntity: Name: NameFull: Watts B – PersonEntity: Name: NameFull: Evans K – PersonEntity: Name: NameFull: Kosasih H – PersonEntity: Name: NameFull: Mayoh C – PersonEntity: Name: NameFull: Erickson SW – PersonEntity: Name: NameFull: Earley EJ – PersonEntity: Name: NameFull: Neuhauser S – PersonEntity: Name: NameFull: Stearns TM – PersonEntity: Name: NameFull: Philip VM – PersonEntity: Name: NameFull: Chuang JH – PersonEntity: Name: NameFull: de Bock CE – PersonEntity: Name: NameFull: Bowman EP – PersonEntity: Name: NameFull: Jessen KA – PersonEntity: Name: NameFull: Jocoy EL – PersonEntity: Name: NameFull: Bult CJ – PersonEntity: Name: NameFull: Teicher BA – PersonEntity: Name: NameFull: Smith MA – PersonEntity: Name: NameFull: Lock RB IsPartOfRelationships: – BibEntity: Dates: – D: 22 M: 07 Text: 2026 Jul 22 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2572-9241 Numbering: – Type: volume Value: 10 – Type: issue Value: 7 Titles: – TitleFull: HemaSphere Type: main |
| ResultId | 1 |